pergolide has been researched along with Pituitary Neoplasms in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (54.05) | 18.7374 |
| 1990's | 6 (16.22) | 18.2507 |
| 2000's | 9 (24.32) | 29.6817 |
| 2010's | 1 (2.70) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Auriemma, RS; Colao, A; Negri, M; Patalano, R; Pirchio, R; Pivonello, C; Pivonello, R | 1 |
| Alkabbani, A; Doshi, K; Hamrahian, A; Hatipoglu, B; Kennedy, L; Makin, V; Mon, SY; Olansky, L; Thorton, JN; Weil, R | 1 |
| Chuman, H; Cornblath, WT; Gebarski, SS; Trobe, JD | 1 |
| Ball, SG; Hall, K; James, RA; Kendall-Taylor, P; Pearce, SH; Quinton, R; Sibal, L; Ugwu, P | 1 |
| Abs, R; Verhelst, J | 1 |
| Chiarelli, F; Galluzzi, F; La Cauza, F; Salti, R; Stagi, S | 1 |
| Molitch, ME | 1 |
| Boulos, PT; Hamilton, DK; Laws, ER; Vance, ML | 1 |
| Cook, DB; Hall, K; Johnston, DG; Kendall-Taylor, P; Patrick, D; Watson, M | 1 |
| Blackwell, RE; Bradley, EL; Chang, RJ; DeVane, GW; Duvall, ER; Kline, LB; Vitek, JJ | 1 |
| Butt, WR; Franks, S; Horrocks, PM; London, DR; Lynch, SS | 1 |
| Debusschere, PM; Deschepper, C; Gillet, C; L'Hermite, M | 1 |
| Deconinck, I; Gillet, C; L'Hermite, M; Legros, JJ; Waucquez, JL | 1 |
| Hall, K; Johnston, DG; Kendall-Taylor, P; Prescott, RW | 1 |
| Boyd, AE; Bryan, N; Frantz, AG; George, A; Greising, J; Hamilton, D; Hilal, S; Kleinberg, DL; Seltzer, T; Sommers, CJ; Wardlaw, S | 1 |
| Blackard, WG | 1 |
| Barkan, AL; Chandler, WF | 1 |
| Arita, N; Hanafusa, T; Hayakawa, T; Kamada, Y; Kawarada, Y; Matsuzawa, Y; Miyagawa, J; Nakajima, H; Namba, M; Saitoh, Y; Sugiyama, T; Yamamoto, K | 1 |
| Andreadis, CI; Bruce, JN; Freda, PU; Jacobs, TP; Khandji, AG; Khoury, M; Wardlaw, SL | 1 |
| Barkan, AL; Chandler, WF; Orrego, JJ | 1 |
| Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R | 1 |
| Berezin, M; Findler, G; Gutman, I; Horowitz, A; Tadmor, R | 1 |
| Lamberts, SW; Quik, RF | 1 |
| Cooper, P; Donahue, B; Lee, C; Newall, J; Persky, M; Rush, S | 1 |
| Jungmann, E; Saeger, W; Schöffling, K; Schumm-Draeger, PM; Steudel, I | 1 |
| Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG | 1 |
| Bernstein, J; Buckman, MT; Mattox, JH | 1 |
| Corenblum, B | 1 |
| Althoff, PH; Fassbinder, W; Haak, T; Jungmann, E; Schöffling, K | 1 |
| Crosignani, PG; Ferrari, C | 1 |
| Ahmed, SR; Shalet, SM | 1 |
| Bernstein, J; Buckman, MT; Kellner, R; Mattox, JH; Pathak, D | 1 |
| Blackwell, RE | 1 |
| Pepperell, RJ | 1 |
| Horvath, E; Kovacs, KT; Laws, ER; Randall, RV; Scheithauer, BW; Whitaker, MD | 1 |
| Besser, GM; Bouloux, PM; Grossman, A; Loneragan, R; Rees, LH; Wass, JA | 1 |
| Adams, CB; Besser, GM; Charlesworth, M; Doniach, I; Grossman, A; Ross, R; Wass, JA | 1 |
7 review(s) available for pergolide and Pituitary Neoplasms
| Article | Year |
|---|---|
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aminoquinolines; beta-Arrestins; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Filamins; Growth Hormone-Secreting Pituitary Adenoma; Humans; Lisuride; MicroRNAs; Pergolide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2 | 2021 |
Hyperprolactinemia: pathophysiology and management.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estrogens; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radiotherapy; Surgical Procedures, Operative | 2003 |
Pharmacologic resistance in prolactinoma patients.
Topics: Bromocriptine; Cabergoline; Cell Proliferation; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Resistance; Ergolines; Estrogens; Female; Humans; Male; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine D2 | 2005 |
Dopamine receptor agonists for treating prolactinomas.
Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma | 2002 |
Medical treatment of pituitary adenomas: effects on tumor growth.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1985 |
Medical treatment of hyperprolactinaemic disorders.
Topics: Acromegaly; Bromocriptine; Delayed-Action Preparations; Dopamine; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Psychoses, Substance-Induced; Tamoxifen | 1986 |
Diagnosis and management of prolactinomas.
Topics: Adenoma; Adult; Diagnosis, Differential; Ergolines; Female; Follow-Up Studies; Galactorrhea; Genital Diseases, Female; Humans; Hypophysectomy; Hypothyroidism; Infertility, Female; Pergolide; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Sella Turcica; Tomography, X-Ray Computed; Visual Field Tests | 1985 |
6 trial(s) available for pergolide and Pituitary Neoplasms
| Article | Year |
|---|---|
Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follicle Stimulating Hormone; Humans; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Thyrotropin | 2002 |
Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study.
Topics: Adolescent; Adult; Aged; Amenorrhea; Bromocriptine; Clinical Trials as Topic; Dopamine; Ergolines; Female; Galactorrhea; Humans; Middle Aged; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Random Allocation | 1983 |
Long-term treatment of prolactin-secreting macroadenomas with pergolide.
Topics: Adolescent; Adult; Aged; Dopamine Agonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone | 2000 |
Pergolide as primary therapy for macroprolactinomas.
Topics: Adolescent; Adult; Amenorrhea; Dopamine Agonists; Female; Galactorrhea; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Visual Fields | 2000 |
A comparison of the efficacy and safety of pergolide and bromocriptine in the treatment of hyperprolactinemia.
Topics: Adult; Amenorrhea; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy; Female; Galactorrhea; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Radiography | 1991 |
Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy
Topics: Adult; Aged; Aldosterone; Blood Pressure; Bromocriptine; Catecholamines; Dopamine; Female; Humans; Kidney; Male; Middle Aged; Norepinephrine; Pergolide; Pituitary Neoplasms; Prolactin; Renin; Stimulation, Chemical | 1988 |
24 other study(ies) available for pergolide and Pituitary Neoplasms
| Article | Year |
|---|---|
Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Thromboembolism; Young Adult | 2013 |
Delayed visual loss following pergolide treatment of a prolactinoma.
Topics: Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactinoma; Vision Disorders; Visual Fields | 2002 |
Reversible weight gain and prolactin levels--long-term follow-up in childhood.
Topics: Adolescent; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Weight Gain | 2005 |
Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Outcome | 2005 |
Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography.
Topics: Adult; Aged; Bromocriptine; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Sella Turcica; Tomography, X-Ray Computed | 1984 |
Effectiveness of pergolide mesylate in long term treatment of hyperprolactinaemia.
Topics: Adult; Ergolines; Female; Humans; Hypogonadism; Male; Menstruation Disturbances; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Time Factors | 1983 |
Treatment of hyperprolactinaemic patients with pergolide.
Topics: Adolescent; Adult; Amenorrhea; Dose-Response Relationship, Drug; Ergolines; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Oligomenorrhea; Pergolide; Pituitary Neoplasms; Prolactin; Time Factors | 1983 |
Pergolide for pituitary tumors secreting prolactin or growth hormone.
Topics: Acromegaly; Ergolines; Female; Growth Hormone; Humans; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin | 1984 |
Reduction in size of prolactin-secreting tumours in men treated with pergolide.
Topics: Antineoplastic Agents; Ergolines; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin | 1982 |
Pergolide for the treatment of pituitary tumors secreting prolactin or growth hormone.
Topics: Acromegaly; Adenoma; Ergolines; Female; Fertility; Growth Hormone; Humans; Male; Menstruation; Pergolide; Pituitary Neoplasms; Prolactin; Testosterone; Tomography, X-Ray Computed | 1983 |
Edema--an infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs.
Topics: Aminoquinolines; Bromocriptine; Dopamine Agents; Edema; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactinoma | 1993 |
Giant pituitary prolactinoma with falsely low serum prolactin: the pitfall of the "high-dose hook effect": case report.
Topics: Adult; Dopamine Agonists; Humans; Luminescent Measurements; Magnetic Resonance Imaging; Male; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma | 1998 |
A case with prolactinoma treated with pergolide and its histology.
Topics: Dopamine Agonists; Female; Humans; Microscopy, Electron; Middle Aged; Pergolide; Pituitary Gland; Pituitary Neoplasms; Prolactinoma | 1998 |
Malignant prolactinoma.
Topics: Bromocriptine; Combined Modality Therapy; Female; Humans; Middle Aged; Orbital Neoplasms; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
Prolactin reduction after combined therapy for prolactin macroadenomas.
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Libido; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Retrospective Studies | 1991 |
Influence of pergolide treatment on xenotransplanted human pituitary tumors of prolactinoma.
Topics: Animals; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Pergolide; Pituitary Neoplasms; Prolactinoma; Transplantation, Heterologous | 1989 |
Control of hyperprolactinemia with pergolide.
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Prolactin | 1986 |
The medical treatment of the hypersecreting pituitary gland.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Cyproheptadine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Valproic Acid | 1985 |
Discordant responses of prolactinoma to two different dopamine agonists.
Topics: Adult; Bromocriptine; Drug Resistance; Ergolines; Female; Humans; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1986 |
Dopamine agonists for reducing depression associated with hyperprolactinemia.
Topics: Analysis of Variance; Bromocriptine; Depression; Depressive Disorder; Drug Evaluation; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Prolactin | 1986 |
Management of prolactinomas. A reappraisal.
Topics: Adenoma; Bromocriptine; Ergolines; Female; Humans; Lisuride; Metergoline; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Radiotherapy Dosage; Radiotherapy, High-Energy; Time Factors | 1985 |
Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases.
Topics: Biological Assay; Brain Neoplasms; Bromocriptine; Combined Modality Therapy; Ergolines; Female; Histocytochemistry; Hormones; Humans; Microscopy, Electron; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pergolide; Pituitary Neoplasms; Prolactin | 1985 |
Comparison of the clinical activity of mesulergine and pergolide in the treatment of hyperprolactinaemia.
Topics: Adenoma; Adult; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin | 1985 |
The effect of dopamine agonist therapy on large functionless pituitary tumours.
Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prospective Studies | 1985 |